| Name | Cvs Pharmacy #11367 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 1120 E Kennedy Blvd, Tampa, Florida 33602 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (813) 469-6213 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and AstraZeneca filed a lawsuit against Dr. Reddy's Laboratories (Dr. Reddy's) in the United States District Court for the District of New Jersey, for infringement of U.S. Patent No. 6,926,907 relating to VIMOVO™ (naproxen / esomeprazole magnesium) delayed-release tablets.
When cells cannot carry out the tasks required of them by our bodies, the result is disease. Nanobiotechnology researchers are looking for ways to allow synthetic systems take over simple cellular activities when they are absent from the cell. This requires transport systems that can encapsulate medications and other substances and release them in a controlled fashion at the right moment. The transporter must be able to interact with the surroundings in order to receive the signal to unload its cargo.
Orthopaedic surgeons and researchers at NYU Langone Medical Center are the first in the Northeast to use a new device that incorporates sensors, microelectronics and wireless communication to provide real-time data about positioning, balance and tension of ligaments during total knee replacement surgery.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
Orexigen® Therapeutics, Inc. announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity. The NDA is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over 4,500 patients.
› Verified 6 days ago
| NPI Number | 1811517758 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY #11367 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1120 E Kennedy Blvd Unit 126, Tampa, FL 33602 |
| Phone Number | 401-765-1500 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and AstraZeneca filed a lawsuit against Dr. Reddy's Laboratories (Dr. Reddy's) in the United States District Court for the District of New Jersey, for infringement of U.S. Patent No. 6,926,907 relating to VIMOVO™ (naproxen / esomeprazole magnesium) delayed-release tablets.
When cells cannot carry out the tasks required of them by our bodies, the result is disease. Nanobiotechnology researchers are looking for ways to allow synthetic systems take over simple cellular activities when they are absent from the cell. This requires transport systems that can encapsulate medications and other substances and release them in a controlled fashion at the right moment. The transporter must be able to interact with the surroundings in order to receive the signal to unload its cargo.
Orthopaedic surgeons and researchers at NYU Langone Medical Center are the first in the Northeast to use a new device that incorporates sensors, microelectronics and wireless communication to provide real-time data about positioning, balance and tension of ligaments during total knee replacement surgery.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
Orexigen® Therapeutics, Inc. announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity. The NDA is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over 4,500 patients.
› Verified 6 days ago
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and AstraZeneca filed a lawsuit against Dr. Reddy's Laboratories (Dr. Reddy's) in the United States District Court for the District of New Jersey, for infringement of U.S. Patent No. 6,926,907 relating to VIMOVO™ (naproxen / esomeprazole magnesium) delayed-release tablets.
When cells cannot carry out the tasks required of them by our bodies, the result is disease. Nanobiotechnology researchers are looking for ways to allow synthetic systems take over simple cellular activities when they are absent from the cell. This requires transport systems that can encapsulate medications and other substances and release them in a controlled fashion at the right moment. The transporter must be able to interact with the surroundings in order to receive the signal to unload its cargo.
Orthopaedic surgeons and researchers at NYU Langone Medical Center are the first in the Northeast to use a new device that incorporates sensors, microelectronics and wireless communication to provide real-time data about positioning, balance and tension of ligaments during total knee replacement surgery.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
Orexigen® Therapeutics, Inc. announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity. The NDA is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over 4,500 patients.
› Verified 6 days ago
6th St. Bridge Mobility Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7818 Depot Ln, Tampa, Florida 33637 Phone: (813) 621-2001 | |
A-ability Medical Equipment Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4010 E Hillsborough Ave, Tampa, Florida 33610 Phone: (813) 620-4475 | |
About You Type: Prosthetic/Orthotic Supplier Location: 3401 Henderson Blvd, Tampa, Florida 33609 Phone: (813) 876-2727 | |
Advance Pharmacy Service Llc Type: Pharmacy Location: 4910 N Armenia Ave, Tampa, Florida 33603 Phone: (813) 350-9999 | |
Advocate Medical Services Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5912 Breckenridge Pkwy, Tampa, Florida 33610 Phone: (813) 280-6547 |